Verrica Pharmaceuticals Inc. Available-for-sale Securities, Equity Securities, Noncurrent
Verrica Pharmaceuticals Inc. (VRCA) had Available-for-sale Securities, Equity Securities, Noncurrent of $0 as of 2020-12-31, per its 10-K filed 2021-03-17.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent · last filed 2021-03-17
- 2020-12-31: Available-for-sale Securities, Equity Securities, Noncurrent $0.00.
- 2019-12-31: Available-for-sale Securities, Equity Securities, Noncurrent $0.00.
- 2018-12-31: Available-for-sale Securities, Equity Securities, Noncurrent $0.00.
- 2018-09-30: Available-for-sale Securities, Equity Securities, Noncurrent $0.00.
| Period end | Available-for-sale Securities, Equity Securities, Noncurrent |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-17 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-13 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-07 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |